Zimbabwe has turned down a major US health deal worth $367m (272 million pounds) over five years over Washington's request for sensitive biological samples.
The decision was revealed after a official document dated December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesman later explained that the US was requesting health data for scientific study and commercial gain but was unwilling to guarantee the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to secure a agreement agreeable to all parties so the nation's vital HIV treatment initiative can proceed.
Wider Implications
This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement following concerns were filed about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
Based on reports, 16 African countries have so far agreed to these new health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to share its genetic material and health information indefinitely, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"In essence, our nation would supply the basic resources for medical research without any certainty that the end products would be available to our population should a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending structures already established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This system is intended to guarantee that when a nation contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how future collaboration might be designed in a manner that honours the independence and interests of each country."
Health Experts Response
Medical experts stated it acknowledged the government's concerns, but suggested that talks must proceed considering a large portion of the nation's Aids initiatives relied on foreign aid.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group said.
The situation highlights the continuing challenges between receiving much-needed international aid and safeguarding a country's data in an ever more data-driven world.